Inkon Life Technology (300143.SZ): Cumulative expenditure of 47.8567 million yuan to repurchase 5.5907 million shares.
On June 3rd, Gelonhui reported that Inkon Life Technology (300143.SZ) announced that as of May 31, 2024, the company repurchased 5,590,652 shares of its own stock through a share repurchase dedicated securities account using centralized bidding trading method, accounting for 0.87% of the company's current total share capital (calculated based on the company's total share capital of 642,167,010 shares after the close of trading on June 3, 2024). The highest and lowest transaction prices for the repurchase were 8.90 yuan/share and 8.09 yuan/share, respectively, and the total transaction amount was RMB 47,856,696.96 (excluding transaction fees).
Yingkang Life (300143.SZ): As of May 20, 2024, the total number of shareholders of the company was 16,540
Gelonghui May 24 | Yingkang Life (300143.SZ) said on the investor interactive platform that as of May 20, 2024, the total number of shareholders of the company was 16,540.
INKON Life Technology Co., Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
It's been a good week for INKON Life Technology Co., Ltd. (SZSE:300143) shareholders, because the company has just released its latest yearly results, and the shares gained 6.7% to CN¥7.95. It w
Yingkang Life (300143.SZ): Net profit of 26.22,900 yuan in the first quarter decreased by 33.69% year-on-year
Gelonghui, April 25 | Yingkang Life (300143.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 416 million yuan, up 15.17% year on year; net profit attributable to shareholders of listed companies was 26.22,900 yuan, down 33.69% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 238.246 million yuan, down 38.55% year on year; basic earnings per share were 0.0410 yuan.
Yingkang Life (300143.SZ) reported 2023 results, with net profit of 100 million yuan, turning a year-on-year loss into a profit
Yingkang Life (300143.SZ) released its 2023 annual report. The company achieved operating income of 14 during the reporting period...
We Think INKON Life Technology (SZSE:300143) Can Manage Its Debt With Ease
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' So it might be obvious that you need to consider debt, whe
Yingkang Life (300143.SZ): A total cost of 2.6973 million yuan to buy back 309,300 shares
Gelonghui, March 4, 丨 Yingkang Life (300143.SZ) announced that as of February 29, 2024, the company had repurchased 309,300 shares of the company's shares through a special stock repurchase account, accounting for 0.05% of the company's current total share capital (calculated based on the company's total share capital of 642,167,010 shares after closing on March 4, 2024). The highest price of the repurchase transaction was 8.82 yuan/share, the lowest price was 8.55 yuan/share, and the total transaction amount was RMB 2.6973 million (excluding transaction fees).
Yingkang Life (300143.SZ): Initial repurchase of 309,300 shares involving 2.6973 million yuan
Gelonghui, Feb. 27丨Yingkang Life (300143.SZ) announced that on February 27, 2024, for the first time, the company repurchased 309,300 shares of the company's shares through a special stock repurchase account, accounting for 0.05% of the company's current total share capital (calculated based on the company's total share capital of 642,167,010 shares after closing on February 27, 2024). The highest price of the repurchase transaction was 8.82 yuan/share, the lowest price was 8.55 yuan/share, and the total transaction amount was RMB 2,6972.97 million (excluding transaction fees).
Yingkang Life (300143.SZ): As of February 20, 2024, the total number of shareholders of the company was 1,7050
Gelonghui, February 22丨Yingkang Life (300143.SZ) said on the interactive platform that as of February 20, 2024, the total number of shareholders of the company was 17,050.
Yingkang Life (300143.SZ): As of January 31, 2024, the total number of shareholders of the company was 17,162
Gelonghui, Feb. 7 | Yingkang Life (300143.SZ) said on the interactive platform that as of January 31, 2024, the total number of shareholders of the company was 17,162.
Yingkang Life (300143.SZ): Plans to spend 40 million yuan to 80 million yuan to buy back the company's shares
Gelonghui February 5 丨 Yingkang Life (300143.SZ) announced that the company plans to use its own funds to repurchase the company's issued RMB common shares (A shares) through centralized bidding transactions. The shares repurchased will be used for subsequent implementation of the equity incentive plan or employee stock ownership plan. If the company fails to use the above purposes within 36 months from the date of completion of this share repurchase, the unused portion shall be cancelled. The total capital used to repurchase shares this time is not less than RMB 40 million and no more than RMB 80 million, and the share repurchase price is not more than RMB 13 per share (all including the principal amount, same below).
INKON Life Technology Co., Ltd.'s (SZSE:300143) Stock Retreats 25% But Revenues Haven't Escaped The Attention Of Investors
INKON Life Technology Co., Ltd. (SZSE:300143) shareholders that were waiting for something to happen have been dealt a blow with a 25% share price drop in the last month. Instead of being rewarded,
Yingkang Life (300143.SZ): 2023 pre-profit of 97 million yuan to 125 million yuan, reversing losses year-on-year
Gelonghui, January 26 | Yingkang Life (300143.SZ) announced its 2023 annual results forecast. Net profit attributable to shareholders of listed companies during the reporting period was 9700.00 million yuan - 125.0 million yuan, loss of 595.9181 million yuan for the same period of the previous year; net profit profit after deducting non-recurring profit and loss of 960.000 yuan - 124.0 million yuan, and loss of 596.9825 million yuan for the same period last year. During the reporting period, net profit attributable to shareholders of listed companies turned a loss into a profit compared to the same period of the previous year. The main reason was that the previous year's results were calculated based on goodwill impairment
Loss-making INKON Life Technology (SZSE:300143) Sheds a Further CN¥397m, Taking Total Shareholder Losses to 46% Over 3 Years
For many investors, the main point of stock picking is to generate higher returns than the overall market. But its virtually certain that sometimes you will buy stocks that fall short of the market a
Yingkang Life (300143.SZ): Received a review inquiry letter from the Shenzhen Stock Exchange regarding the application for an increase
Glonghui December 12丨Yingkang Life (300143.SZ) announced that on December 12, 2023, the company received the “Audit Inquiry Letter on Yingkang Life Technology Co., Ltd.'s application to issue shares to specific targets” (Audit Letter [2023] No. 020155) from the Shenzhen Stock Exchange. The Shenzhen Stock Exchange's issuance and listing review agency reviewed the company's application documents for issuing shares to specific targets, and formed audit questions. In accordance with the requirements of the above inquiry letter, the company will work with relevant intermediaries to implement and submit responses to the inquiry letter in a timely manner. The content of the response will be passed through the Provisional Public Administration
Yingkang Life (300143.SZ): Applications to issue shares to specific targets were accepted by the Shenzhen Stock Exchange
Glonghui November 24 | Yingkang Life (300143.SZ) announced that on the evening of November 23, 2023, the company received the “Notice on Accepting Application Documents for Issuance of Shares by Yingkang Life Technology Co., Ltd.” from the Shenzhen Stock Exchange (“Shenzhen Stock Exchange”) (Shenzhen Stock Exchange) (Shenzhen Stock Exchange) (Shenzhen Stock Exchange). The Shenzhen Stock Exchange checked the application documents submitted by the company to issue shares to specific targets. It is believed that the application documents are complete and decided to accept them.
Yingkang Life (300143.SZ): Yingkang Lifetime plans to acquire a total of 70% shares in Uni Devices
Glonghui November 9 | Yingkang Life (300143.SZ) announced that Yingkang Yisheng (Shenzhen) Medical Devices Co., Ltd. (“Yingkang Yisheng”), a wholly-owned subsidiary of the company, acquired 70% of the shares of Unimedick (Shenzhen) Co., Ltd. (“Uni Devices”) through direct acquisitions and indirect purchases (hereinafter collectively referred to as “this transaction”). After the transaction is completed, Uni Devices will become a holding subsidiary of the company and will be included in the scope of the company's consolidated statements. The total amount of this round of transactions is RMB 123.9 million, and is based on the actual net profit of Uni Devices from 2023 to 2025
Yingkang Life (300143.SZ): Haier Biotech provides Sichuan Friendship Hospital with equipment and solutions such as medicine dispensers, outpatient pharmacy dispensers, operating room hair and shoe machines, and high-value consumables cabinets
Glonghui November 9 | Yingkang Life (300143.SZ) held an investor relations event on November 8, 2023, on “Does Haier Biotech currently cooperate with the company? Are there any substantial joint projects between the company and Haier Biotech?” The company said that between 2021-2023, Haier Biotech will provide equipment and solutions for Sichuan Friendship Hospital, a wholly-owned subsidiary of the company, such as medicine dispensers, outpatient pharmacy dispensers, operating room hair clothes, shoe machines, and high-value consumables cabinets to help improve hospital service levels.
Yingkang Life (300143.SZ): Currently, no brain-computer interface-related research and development has been carried out
Gelonghui November 9 | Yingkang Life (300143.SZ) held an investor relations event on November 8, 2023. “Does your company have any reserves for brain-computer interface-related technology? Will research and deployment be carried out in the direction of brain-computer interfaces in the future?” The company stated that the company is currently not carrying out research and development related to brain-computer interfaces.
Yingkang Life (300143.SZ) released the results for the first three quarters, with net profit of 94.054 million yuan, an increase of 69.43%
Yingkang Life (300143.SZ) released its report for the third quarter of 2023, and achieved operating income of 11 in the first three quarters...
No Data